KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Buildings (2016 - 2024)

Historic Buildings for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Biogen's Buildings rose 899.32% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 899.32%. This contributed to the annual value of $2.1 billion for FY2025, which is 899.32% up from last year.
  • According to the latest figures from Q4 2025, Biogen's Buildings is $2.1 billion, which was up 899.32% from $2.0 billion recorded in Q4 2024.
  • In the past 5 years, Biogen's Buildings ranged from a high of $2.1 billion in Q4 2025 and a low of $1.6 billion during Q4 2022
  • Its 5-year average for Buildings is $1.8 billion, with a median of $1.7 billion in 2021.
  • Per our database at Business Quant, Biogen's Buildings soared by 6577.59% in 2021 and then tumbled by 628.35% in 2022.
  • Biogen's Buildings (Quarter) stood at $1.7 billion in 2021, then dropped by 6.28% to $1.6 billion in 2022, then rose by 0.53% to $1.6 billion in 2023, then increased by 22.63% to $2.0 billion in 2024, then rose by 8.99% to $2.1 billion in 2025.
  • Its Buildings stands at $2.1 billion for Q4 2025, versus $2.0 billion for Q4 2024 and $1.6 billion for Q4 2023.